Breaks Categories: News

FridayDec 17, 2021 2:28 pm

NetworkNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Advancing MYCO-001 to Bring Safer, More Effective Smoking Cessation Treatment to Market

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, today published a blog article discussing positive clinical data assessing psilocybin for smoking cessation and its upcoming clinical trials. The piece, titled “Why We’re Bullish on MYCO-001, 99% Psilocybin, to Treat Nicotine Dependance,” covers Mydecine’s partnership with Dr. Matthew Johnson and Johns Hopkins University to advance its lead drug candidate MYCO-001 as a smoking cessation treatment. The company’s phase 2/3 smoking cessation clinical trial, set to launch in early 2022, builds from Dr. Johnson’s previous research…

Continue Reading

FridayDec 17, 2021 11:33 am

NetworkNewsBreaks – Keynote to Continue Collaboration with CryptoCurrencyWire for Upcoming Bitcoin Conference

Keynote and CryptoCurrencyWire (“CCW”), one of more than 50 brands offered through InvestorBrandNetwork (“IBN”), will continue their ongoing collaboration for the upcoming North American Bitcoin Conference, with CCW serving as the official newswire for the conference. Keynote is presenting the in-person and online event, which is scheduled to take place Jan. 17–19, 2022; those attending in person will be gathering at the James L. Knight Center in Miami, Florida. The North American Bitcoin Conference has built a reputation for being the blockchain and crypto industry’s must-attend event. The three-day conference is designed to be a rich resource of industry information and to help participants make…

Continue Reading

FridayDec 17, 2021 10:24 am

NetworkNewsBreaks – StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Announces New CEO

StraightUp Resources (CSE: ST) (OTCQB: STUPF), a public company engaged in the business of mineral exploration and the acquisition of mineral property assets in North America, has announced the appointment of a new CEO: Rod Husband. An accomplished entrepreneur and economic geologist with more than 30 years of experience in the international commodity and finance sectors, Husband has garnered impressive experience in the exploration and development of companies. He has served as director and officer of several Canadian public companies and has raised more than $150 million for those companies. “We are excited to have Mr. Husband’s caliber of leadership…

Continue Reading

FridayDec 17, 2021 9:42 am

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Enters Strategic Media Agreement with SRAX Inc. (NASDAQ: SRAX)

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced its entry into an advertising and media agreement for media buys and digital marketing with SRAX (NASDAQ: SRAX). Under the agreement, SRAX will act as the agent for Lexaria and will engage and manage media companies to create advertising materials and distribute them on internet platforms as well as manage the flow of such media distributions. SRAX will employ leading-edge analytical algorithms in order to maximize engagement. “Lexaria is pleased to be working with SRAX to inform and engage a broad investor community in this significant, year-long…

Continue Reading

ThursdayDec 16, 2021 1:00 pm

NetworkNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Co-Founder, CEO Featured on ‘Gamechangers LIVE’

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), the leading psychedelic wellness platform, was featured in a recent episode of Gamechangers LIVE, a podcast series that shines a spotlight on individuals who are gamechangers in their fields and shares perspective on their journeys, mindsets, struggles and successes in an effort to inspire and inform listeners. Delic’s CEO and Co-Founder Matt Stang joined the broadcast, hosted by Executive Coach and Speaker Sergio Tigera, to discuss his background in the alternative drugs sector, the groundswell of clinical and regulatory developments relating to psychedelics and how Delic is supporting those advancements through its portfolio of…

Continue Reading

ThursdayDec 16, 2021 12:18 pm

NetworkNewsBreaks – Moon Equity Holdings Corp. (MONI) to Launch Unique Product in the Crypto Space

Moon Equity Holdings (OTC: MONI) today announced that it will soon launch a new product, which the company believes is the first-of-its-kind for the crypto industry. According to the update, the product offers unique features and enables the exchange and growth appreciation of crypto. Moon Equity Holdings is currently building a specialized website and backend system for the product and has additionally completed the acquisition of the BitGift card, with trademark details to be disclosed in the company’s financials. To be available as a virtual or actual physical card for customers, the company looks forward to the pending launch of the…

Continue Reading

ThursdayDec 16, 2021 11:40 am

NetworkNewsBreaks – The ‘Sky’s the Limit’ Touted at SiGMA Europe’s Malta Week

SiGMA’s flagship event, SiGMA Europe, was held to great acclaim last month at the Malta Fairs and Convention Centre. SiGMA Europe brought four key conferences together for SiGMA’s largest event to date — the week-long Malta Week. The multidisciplinary celebration and exploration of the commercial and technological synergies within the emerging tech, digital and affiliate marketing and gaming sectors drew more than 10,000 guests and 100s of corporate exhibitors. Featuring engaging keynotes by Malta Prime Minister Robert Abela and pop star Akon, the event commenced with a rousing speech delivered by the SiGMA Foundation’s Keith Marshall, who urged attendees that…

Continue Reading

ThursdayDec 16, 2021 11:18 am

NetworkNewsBreaks – AmpliTech Group Inc. (NASDAQ: AMPG) Releases Acquisition Update, Anticipated Results

AmpliTech Group (NASDAQ: AMPG), a designer, developer and manufacturer of state-of-the-art, signal-processing components for satellite and 5G communications networks, defense, space and other commercial applications, has completed the purchase of the assets and operations of Spectrum Semiconductor Materials Inc. Based in California, Spectrum is a rapidly growing global specialty distributor of semiconductor components. According to AMPG, the transaction should provide significant financial benefits to the company while also adding significant distribution reach. The announcement noted that Spectrum is on track to reach unaudited 2021 revenue $13 million unaudited revenue for 2021. The announcement also observed that Spectrum has an existing…

Continue Reading

ThursdayDec 16, 2021 10:53 am

NetworkNewsBreaks – RYAH Group Inc. (CSE: RYAH) to Collaborate with OMNI Medical Services for Cannabis Study in Treatment of COVID-19

RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, has announced plans for a U.S. clinical study focused on treatment COVID-19. RYAH will be partnering with OMNI Medical Services to perform the U.S.-based clinical study evaluating patients using inhalation of medical cannabis to both treat and prevent the coronavirus. The study, which will run for five years, will involve the use of RYAH’s Smart Inhaler devices and will involve up to 11,000 of OMNI’s patients across the country. Phase 2 of the…

Continue Reading

ThursdayDec 16, 2021 10:09 am

NetworkNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Announces Significant Milestone That Brings iSTRYM Closer to Commercial Deployment

Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) (“MINDCURE”), a leader in advanced proprietary technology and research for psychedelics, today announced that the company and its digital therapeutics technology, iSTRYM, have been certified as Health Insurance Portability and Accountability Act (“HIPAA”) compliant. HIPAA compliance certification reflects MINDCURE’s commitment to achieving the highest standards of medical data protection and privacy and is the next step in working towards having the iSTRYM technology platform classified a “Software as a Medical Device” by the FDA. “Receiving HIPAA compliance is a significant milestone for MINDCURE, which supports our goal of commercially deploying iSTRYM…

Continue Reading